Last reviewed · How we verify
NeuroAiD — Competitive Intelligence Brief
marketed
Herbal neuroprotective agent
Neurology
Small molecule
Live · refreshed every 30 min
Target snapshot
NeuroAiD (NeuroAiD) — CHIMES Society. NeuroAiD is a traditional Chinese medicine-derived neuroprotective agent that promotes neuronal survival and enhances neuroplasticity following acute ischemic stroke.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| NeuroAiD TARGET | NeuroAiD | CHIMES Society | marketed | Herbal neuroprotective agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Herbal neuroprotective agent class)
- CHIMES Society · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- NeuroAiD CI watch — RSS
- NeuroAiD CI watch — Atom
- NeuroAiD CI watch — JSON
- NeuroAiD alone — RSS
- Whole Herbal neuroprotective agent class — RSS
Cite this brief
Drug Landscape (2026). NeuroAiD — Competitive Intelligence Brief. https://druglandscape.com/ci/neuroaid. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab